CUV 0.60% $15.16 clinuvel pharmaceuticals limited

Still Undervalued, page-3

  1. 90 Posts.
    lightbulb Created with Sketch. 1
    Absolutely. I should have added that given the low volume the stock will continue to be vulnerable to manipulation, and there could be a volatile period ahead.

    My sentiment is "buy" but I wish there was an option for "longterm buy" because that's far more accurate. I enjoy checking in everyday (especially on a day like this) but I'm looking a year or two ahead.

    Obviously a takeover offer would change everything. There's no rush for a big pharma to make an offer, they don't have to be the first, they just have to be the highest. If it's as derisked as many believe, then a number of companies will be running the numbers.

    I always figured an offer would come after steady income from the US, but maybe that's just wishful thinking.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.16
Change
0.090(0.60%)
Mkt cap ! $759.1M
Open High Low Value Volume
$15.12 $15.44 $15.02 $1.063M 70.10K

Buyers (Bids)

No. Vol. Price($)
1 126 $15.14
 

Sellers (Offers)

Price($) Vol. No.
$15.27 764 3
View Market Depth
Last trade - 16.10pm 17/09/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.